Joshua F. Zeidner, Tara L. Lin, Rina Li Welkie, Emily Curran, Kristin Koenig, Wendy Stock, Yazan F. Madanat, Ronan Swords, Maria R. Baer, William Blum, Eytan M. Stein, Rebecca L. Olin, Gary Schiller, Angela Nichols, Olatoyosi Odenike, Elie Traer, Curtis Lachowiez, Vu H. Duong, Michael J. Hochman, Sheng F. Cai, Catherine Smith, Mona Stefanos, Molly Martycz, Ying Huang, Len Rosenberg, Sonja Marcus, Timothy L. Chen, Ashley O. Yocum, Brian J. Druker, Ross L. Levine, Uma Borate, John C. Byrd, Alice S. Mims. "Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed
                    <i>NPM1</i>
                    -Mutated or
                    <i>KMT2A</i>
                    -Rearranged AML." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-00914